Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes

NCT01509755 · Completed

Last updated 2026-05-28

This clinical trial compared the effects of liraglutide and glimepiride on blood sugar control in adults with type 2 diabetes.

Status Completed The study has finished.

Phase Phase 2 Tests whether it works and watches safety in a moderate group.

Type Interventional (clinical trial)

Participants 196 people Planned (estimated).

Who can join Ages 30–75 · all sexes

Timeline Started 2000-10 · est. completion 2001-10

Where 29 sites · Denmark, Norway, Sweden, United Kingdom

What this study is testing ClinicalTrials.gov NCT01509755 ↗

Description as written by the study sponsor.

This trial is conducted in Europe. The aim of this trial is to establish the dose response relationship on glycaemic control of five dose levels of NNC90-1170.

Treatments tested

placebo Drug

Once daily injection, under the skin (s.c.) for 12 weeks
liraglutide also known as NNC 90-1170 Drug

Once daily injection, under the skin (s.c.) for 12 weeks
glimepiride Drug

Tablets administered orally according to current treatment guidelines. Dose adjusted according to the glycaemic response

Main thing measured	HbA1c (glycosylated haemoglobin)
Sponsor	Novo Nordisk A/S
Conditions studied	Diabetes, Diabetes Mellitus, Type 2
GLP-1 drugs	liraglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT01509755 ↗